.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Accenture
AstraZeneca
Express Scripts
Deloitte
Healthtrust
Fish and Richardson
Merck
Cantor Fitzgerald
Citi

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200670

« Back to Dashboard
NDA 200670 describes LEVONORGESTREL, which is a drug marketed by Novel Labs Inc, Wyeth Pharms Inc, Lupin Ltd, Perrigo R And D, Mylan Labs Ltd, Glenmark Pharms Ltd, Reckitt Benckiser, Watson Labs, Watson Labs Inc, Oc Pharma, Lotus Pharm Co Ltd, Mayne Pharma, Amneal Pharms, Barr, and Glenmark Generics, and is included in thirty-seven NDAs. It is available from sixteen suppliers. Additional details are available on the LEVONORGESTREL profile page.

The generic ingredient in LEVONORGESTREL is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

Summary for 200670

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 200670

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVONORGESTREL
levonorgestrel
TABLET;ORAL 200670 ANDA Actavis Pharma, Inc. 52544-065 52544-065-54 1 BLISTER PACK in 1 CARTON (52544-065-54) > 1 TABLET in 1 BLISTER PACK
LEVONORGESTREL
levonorgestrel
TABLET;ORAL 200670 ANDA NuCare Pharmaceuticals,Inc. 68071-1642 68071-1642-1 1 TABLET in 1 BOX (68071-1642-1)

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength1.5MG
Approval Date:Jul 12, 2012TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
UBS
Fuji
Boehringer Ingelheim
Queensland Health
Dow
QuintilesIMS
Colorcon
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot